Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-26 @ 5:25 AM
Study NCT ID:
NCT00673660
Status:
COMPLETED
Last Update Posted:
2021-02-21
First Post:
2008-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Study Overview
Official Title:
Assessment Of Statin Treatment Compliance In Dyslipidemia Patients: An Observational Study
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to show the compliance rates of the patients to statin treatment and the reasons of non-compliance.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: